Lats2 is critical for the pluripotency and proper differentiation of stem cells

Cell Death and Differentiation

Volumn 21, Issue 4, 2014, Pages 624-633

  Aylon, Y ^a   Sarver, A ^a   Tovy, A ^a   Ainbinder, E ^a   Oren, M ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

bivalent chromatin; Hippo; Lats2; p53; stem cells; Yap

Indexed keywords

LATS2 PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; DEVELOPMENTAL GENE; EMBRYO; EMBRYONIC STEM CELL; FEEDBACK SYSTEM; FEMALE; GERM LAYER; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE EMBRYO; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANEUPLOIDY; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; HEPATOCYTES; MICE; MICE, INBRED C57BL; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84903372189     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.188     Document Type: Article

References (60)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
2. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-1135.
3. Sarig R, Rivlin N, Brosh R, Bornstein C, Kamer I, Ezra O et al. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med 2010; 207: 2127-2140.
4. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460: 1140-U1107.
5. Zhao Y, Yin XL, Qin H, Zhu FF, Liu HS, Yang WF et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008; 3: 475-479.
6. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460: 1149-U1119.
7. Suva ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013; 339: 1567-1570.
8. Orkin SH, Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011; 145: 835-850.
9. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
10. Pomerantz JH, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development 2013; 140: 2502-2512.
11. Oren MaYA (ed.). The Hippo Signaling Pathway and Cancer. 1st edn. Springer Science & Business Media: New York, 2013.
12. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491-505.
13. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24: 72-85.
14. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al. Role of YAP/TAZ in mechanotransduction. Nature 2011; 474: 179-U212.
15. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 2010; 24: 1106-1118.
16. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 2009; 16: 398-410.
17. Zhou DW, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16: 425-438.
18. Visser S, Yang X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 2010; 9: 3892-3903.
19. Kostic C, Shaw PH. Isolation and characterization of sixteen novel p53 response genes. Oncogene 2000; 19: 3978-3987.
20. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 2006; 20: 2687-2700.
21. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X et al. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 2010; 24: 2420-2429.
22. McPherson JP, Tamblyn L, Elia A, Migon E, Shehabeldin A, Matysiak-Zablocki E et al. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J 2004; 23: 3677-3688.
23. Yabuta N, Okada N, Ito A, Hosomi T, Nishihara S, Sasayama Y et al. Lats2 is an essential mitotic regulator required for the coordination of cell division. J Biol Chem 2007; 282: 19259-19271.
24. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008; 132: 661-680.
25. Shi G, Jin Y. Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res Ther 2010; 1: 39.
26. Thomson M, Liu SJ, Zou LN, Smith Z, Meissner A, Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011; 145: 875-889.
27. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97: 11307-11312.
28. Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006; 44: 1478-1486.
29. Pal R, Khanna A. Role of hepatocyte-like cells in the differentiation of cardiomyocytes from mouse embryonic stem cells. Stem Cells Dev 2005; 14: 153-161.
30. Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 2010; 28: 1079-1088.
31. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
32. Avruch J, Zhou D, Fitamant J, Bardeesy N, Mou F, Barrufet LR. Protein kinases of the Hippo pathway: regulation and substrates. Semin Cell Dev Biol 2012; 23: 770-784.
33. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130: 1120-1133.
34. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012; 26: 1300-1305.
35. Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H et al. Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene 2009; 28: 4469-4479.
36. Lorthongpanich C, Messerschmidt DM, Chan SW, Hong W, Knowles BB, Solter D. Temporal reduction of LATS kinases in the early preimplantation embryo prevents ICM lineage differentiation. Genes Dev 2013; 27: 1441-1446.
37. Bernstein BE, Mikkelsen TS, Xie XH, Kamal M, Huebert DJ, Cuff J et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
38. Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8: 532-U189.
39. Roh TY, Cuddapah S, Cui KR, Zhao KJ. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006; 103: 15782-15787.
40. Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007; 6: 1040-1043.
41. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013; 154: 61-74.
42. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147: 759-772.
43. Tamm C, Bower N, Anneren C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 2011; 124(Pt 7): 1136-1144.
44. Septer S, Edwards G, Gunewardena S, Wolfe A, Li H, Daniel J et al. Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol 2012; 302: G493-G503.
45. Yabuta N, Okada N, Ito A, Hosomi T, Nishihara S, Sasayama Y et al. Lats2 is an essential mitotic regulator required for the coordination of cell division. J Biol Chem 2007; 282: 19259-19271.
46. McPherson JP, Tamblyn L, Elia A, Migon E, Shehabeldin A, Matysiak-Zablocki E et al. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J 2004; 23: 3677-3688.
47. St John MAR, Tao WF, Fei XL, Fukumoto R, Carcangiu ML, Brownstein DG et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 1999; 21: 182-186.
48. Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, Zwaka TP et al. p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 2012; 10: 2.
49. Lin TX, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E et al. P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-U180.
50. Li MM, He YL, Dubois W, Wu XL, Shi JX, Huang J. Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 2012; 46: 30-42.
51. Tamm C, Bower N, Anneren C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 2011; 124: 1136-1144.
52. Lian I, Kim J, Okazawa H, Zhao JG, Zhao B, Yu JD et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Gene Dev 2010; 24: 1106-1118.
53. Chia NY, Chan YS, Feng B, Lu XY, Orlov YL, Moreau D et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 2010; 468: 316-U207.
54. Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi ZX et al. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum Mol Genet 2012; 21: 2054-2067.
55. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 2008; 10: 837-848.
56. Qin H, Yu T, Qing T, Liu Y, Zhao Y, Cai J et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2007; 282: 5842-5852.
57. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-171.
58. Armesilla-Diaz A, Bragado P, Del Valle I, Cuevas E, Lazaro I, Martin C et al. p53 regulates the self-renewal and differentiation of neural precursors. Neuroscience 2009; 158: 1378-1389.
59. An Y, Kang Q, Zhao Y, Hu X, Li N. Lats2 modulates adipocyte proliferation and differentiation via Hippo signaling. PLoS One 2013; 8: e72042.
60. Jukam D, Xie B, Rister J, Terrell D, Charlton-Perkins M, Pistillo D et al. Opposite feedbacks in the Hippo pathway for growth control and neural fate. Science 2013; 342: 1238016.